IkBb/NF-kB p65 Homodimer Complex

Joe Duke-Cohan '22 and Andrew Savidge '21


Contents:


I. Introduction

The nuclear factor-kB (NF-kB) family of eukaryotic transcription factors (TFs) are collectively involved in effecting change at both the organismal and cellular levels through regulation of gene expression related to immune and inflammatory responses as well as cellular growth and apoptosis, respectively (Kumar et al., 2004). The critical nature of the genes over which NF-kB proteins exert control within these roles is evident from the disorders arising from abnormal NF-kB constitutive activation, including general immune diseases such as arthritis, inflammatory bowel disease, and inflammatory lung disease as well diverse cellular dysregulatory conditions (cancers) from leukemia and lymphoma to neuroblastomas and glioblastomas (Okamoto, 2006; Atreya et al., 2008; Park & Christman, 2006; Herwamana et al., 2008; Staudt, 2000; Widera et al., 2007; Smith et al., 2007).

The NF-kB TFs are related structurally by a ~300 residue homologous peptide sequence (a majority of their structure), the Rel homology region (RHR), and by their shared activity as homo- and heterodimers whose integrative diversity contributes to extensively variable DNA-binding capacity (Mosialos & Gilmore, 1993). Furthermore, NF-kB TFs are functionally related by interactions with IkB proteins that inhibit NF-kB nuclear localization and DNA-binding, relegating the resulting IkB-NF-kB complexes to the cytoplasm. One of the more common complexes is that formed between IkBb and the p65 homodimer. The ligand-dependent ubiquitination and phosphorylation of the former within the cytoplasm leads to its degradation and the release of the p65 homodimer to the nucleus where it takes effect (Fig. 1). Though, as Malek et al. (2003) show, hypophosphorylated IkBb-p65 homodimer complex may also migrate as a whole into the nucleus and bind DNA in a stable complex. Phosphorylation and acetylation of the latter also contributes to its DNA-binding capacity.

 

Figure 1. Annotated pathway of induction of IkBb degradation and release of p65 homodimer to localize to the nucleus and effect transcriptional change. Red oval represents IkBb. Blue circles represent p65 TF subunits. Green circle represents phosphate group(s).


II. General Structure

The IkBb/NF-kB p65 homodimer complex is comprised of one 359 residue IkBb , 38.04 kDa in weight, bound to two dimerized NF-kB p65 TF , both 273 residues and 30.97 kDa in weight (note that the full p65 subunit chains are not depicted in complex with IkBb because their structures could not be fully ascertained in complex by Malek et al. (2003); the full structures are, however, depicted bound as a dimer to DNA).

The IkBb inhibitor is comprised of 6 , each consisting of two antiparallel a-helices linked by a sharp loop. In turn, each repeat is followed on either end by a short B-hairpin turn whose 180-degree turn retains the parallel orientation of the repeat domain. Hydrophobic stacking between the helices of the ankyrin repeats stabilizes the extended structure of IkBb. Each p65 subunit has a bipartite structure consisting of an N-terminal RHR and a C-terminal transactivation domain (TAD) separated by a nuclear localization signal (NLS) . The RHR is folded into two immunoglobulin-like domains that contribute to DNA-binding specificity while the TAD contributes to dimerization stability (*Chen et al., 1998) through a selection of hydrophobic and polar contacts: Cys 197, Asn 200, Phe 213, Leu 215, His 245, Val 248, Ala 249 and Val 251 form a at the dimer interface. Arg 198, Cys 216, Asp 217, Asp 243, His 245 and Arg 246 make .

Linkage between IkBb and the p65 homodimer is mediated by interactions between the first two ankyrin repeats of IkBb and the NLS domain of p65 subunit A, as well as contacts made between the last three ankyrin repeats of IkBb and the dimerization domain of the p65 subunits . Within the NLS domain, sandwiched stacking between Phe73 and Phe76 of IkBb and Phe318 (Phe318 not pictured) of p65 subunit A provides particularly stability among other (as well as salt bridge and polar contacts). 'Tis important to note that the minimal extended surface contact between IkBb and the p65 homodimer and the resultant reliance on individual single and sparse interactions is largely due to the bent structure of the ankyrin repeat domain and its limited shared surface area with the planar dimerization surface of the two p65 subunits. Nonetheless, in total, ~4000 Å2 of the surface area of the IkBb/NF-kB p65 homodimer complex - roughly half of its total surface area is buried (Malek et al., 2003).


III. Signaling

Signaling is essential in regulating the activity of both the IkBb/NF-kB p65 homodimer complex as a whole, as well as the p65 homodimer during its functioning as a transcription factor after release form the IkBb inhibitor. The most immediately effective regulatory step in control of the complex is the signal for degradation of the IkBb inhibitor and the subsequent release of the p65 homodimer to localize to the nucleus. This step is primarily controlled by phosphorylation of selective residues such as Ser32 and Ser36 and polyubiquitination of Lys9 within a signal response region of IkBb (overlapping the NLS therein as well) (Fig. 2). Phosphorylation of all IkB proteins occurs via three pathways involving kinase cascades. The canonical pathway is that by which pro-inflammatory cytokines recruit adaptor proteins to the cytoplasmic membrane where they, in turn, recruit IkB-kinase (IKK) complex to phosphorylate IkB. IkB is then ubiquitinated and degraded by protease activity, releasing the attached NF-kB dimer whose NLSs are now available to signal its travel to the nucleus where it can bind DNA and act in conjugation with other TFs to activate targeted transcription (Viatour et al., 2005). The release of the dimer is facilitated by the fact that IkB, as aforementioned, makes minimal and localized contact with the p65 homodimer, so degradation of IkBb affects release faster than would a protein with weaker but more extensive hydrophobic surface contacts.

Chemical modification of the p65 homodimer affects its later interactions at transcription sites. For example, phosphorylation of on either p65 subunit has the potential to change the dimer’s interactions with cofactors, variably determining the gene set it can coactivate. Acetylation of the p65 subunits also affects their activational capacity, specifically, acetylation of and Lys310 (Lys310 not pictured). Acetylation of Lys221 enhances p65 homodimer DNA binding, potentially by impairing interactions with IkBb. Acetylation of Lys310 is required for effective transcriptional activation, though not for DNA binding, potentially indicative of it being required for binding to cofactors (Chen et al., 2004).

 

Figure 2. Annotated peptide sequence of IkBb (residues 1-49) containing the signal response region (residues 5-42). Polyubiquination target lysine and phosphorylation target serines are all marked in red.


IV. DNA Binding

As aforementioned, the combinatiorial diversity of the various NF-kB transcription factors facilitates their variable DNA binding capacity. Specifically, the p65 homodimer binds a 10 bp 5’ NGGRNTTTCC 3’ (5’ GGAAANYCCN 3’ reverse complementary) consensus sequence by a mixture of van der Waals and polar interactions nonspecifically to the DNA sugar-phosphate backbone and with sequence specificity to bases within the helix (**Chen et al., 1998). Both subunit A and subunit B of the p65 homodimer have van der Waals contacts on the backbone with Pro189 on both subunits interacting with phosphates linked to antiparallel adenine nucleotides . Additionally, Tyr36 on both subunits intercalates between pairs of thymines on each strand with the base of each side chain having polar interactions with the nearby phosphates as well.

Though both subunit A and subunit B retain polar interactions with the backbone, only subunit A makes polar bonds to bases with sequence specificity . Besides the aforementioned thymine intercalation, Arg187 donates a hydrogen bond to O4 of the more terminal thymine contacted by Tyr36. Arg35 hydrogen bonds O6 and N7 of the guanine two bases terminal to Tyr36, while Arg33 hydrogen bonds O6 and N7 of the guanine one base terminal to Tyr36, and Glu39 hydrogen bonds N4 of the cytosine immediately terminal to Tyr36.



V References

Kumar, A. et al. (2004). Nuclear factor-kappaB: its role in health and disease. Journal of molecular medicine, 82(7): 434-448.

Okamoto, T. (2006). NF-kappaB and rheumatic diseases. Endocrine, metabolic and immune disorders drug targets, 6(4): 359-372.

Atreya, I. et al. (2008). NF-kappaB in inflammatory bowel disease. Journal of internal medicine, 263(6): 591-596.

Park, G.Y. & Christman, J.W. (2006). Nuclear factor kappa B is a promising therapeutic target in inflammatory lung disease. Current drug targets, 7(6): 661-668.

Herwamana, S. et al. (2008). The NF-kappaB subunit Rel A is associated with in vitro survival and clinical disease progression in chronic lymphocytic leukemia and represents a promising therapeutic target. Blood, 119(9): 4681-4689.

Staudt, L.M. (2000). The molecular and cellular origins of Hodgkin’s disease. The journal of experimental medicine, 191(2): 207-212.

Widera, D. et al. (2007). Neural stem cells, inflammation and NF-kappaB: basic principle of maintenance and repair or origin of brain tumours? Journal of cellular and molecular medicine, 12(2): 459-470.

Smith, D. et al. (2008). NF-kappaB controls growth of glioblastomas/astrocytomas. Molecular and cellular biochemistry, 307(1-2): 141-147.

Mosialos, G., & Gilmore, T.D. (1993). v-Rel and c-Rel are differentially affected by mutations at a consensus protein kinase recognition sequence. Oncogene, 8(3): 721-730.

Malek, S. et al. (2003). X-ray crystal structure of an IkBb/NF-kB p65 homodimer complex. Journal of biological chemistry, 278: 23094-23100.

*Chen, F.E. et al. (1998). Crystal structure of p50/65 heterodimer of transcription factor NF-kB bound to DNA. Nature, 391: 410-413.

Viatour, P. et al. (2005). Phosphorylation of NF-kB and IkB proteins: implications in cancer and inflammation. Trends in biochemical sciences, 40(1): 43-52.

Chen, L.F. et al. (2004). Shaping the nuclear action of NF-kB. Nature reviews molecular cell biology, 5: 392-401.

**Chen, Y.Q. et al. (1998). A novel DNA recognition mode by the NF-kB p65 homodimer. Nature, 5(1): 67-73.

Back to Top